01:32:42 EDT Tue 19 Mar 2024
Enter Symbol
or Name
USA
CA



Medicure Inc (2)
Symbol MPH
Shares Issued 15,881,760
Close 2018-04-23 C$ 6.40
Market Cap C$ 101,643,264
Recent Sedar Documents

Medicure to release 2017 results April 30

2018-04-24 10:51 ET - News Release

An anonymous director reports

MEDICURE TO ANNOUNCE FISCAL YEAR END 2017 FINANCIAL RESULTS ON APRIL 30, 2018

Medicure Inc. will release financial results for the year ended Dec. 31, 2017, after market close on Monday, April 30, 2018. Medicure will hold a conference call and webcast regarding the results on Tuesday, May 1, 2018, at 7:30 a.m. CT (8:30 a.m. ET).

Conference call info

Topic:  Medicure's fiscal year-end 2017 results

Call date:  Tuesday, May 1, 2018

Time:  7:30 a.m. CT (8:30 a.m. ET)

Canada toll-free:  1-888-465-5079; Canada toll: 1-416-216-4169

United States toll-free:  1-888-545-0687

Passcode:  6321868 followed by the pound key

Webcast:  This conference call will be webcast live over the Internet and can be accessed from the Medicure investor relations page on the Medicure website.

You may request international country-specific access information by e-mailing the company in advance. Management will accept and answer questions related to the financial results and operations during the question-and-answer period at the end of the conference call. A recording of the call will be available following the event at the company's website.

About Medicure Inc.

Medicure is a pharmaceutical company focused on the development and commercialization of therapeutics for the U.S. cardiovascular market. The primary focus of the company is the marketing and distribution of Aggrastat (tirofiban hydrochloride) injection and the launch of Zypitamag (pitavastatin magnesium) in the United States, where it is sold through the company's U.S. subsidiary, Medicure Pharma Inc.

© 2024 Canjex Publishing Ltd. All rights reserved.